Back to Search
Start Over
PB1904: TRIAL IN PROGRESS: A PHASE III STUDY OF ASCIMINIB VS AN INVESTIGATOR‐SELECTED TKI IN PATIENTS WITH NEWLY DIAGNOSED CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE (CML‐CP)
- Source :
- HemaSphere; 2022 Supplement 3, Vol. 6, p1783-1784, 2p
- Publication Year :
- 2022
Details
- Language :
- English
- ISSN :
- 25729241
- Volume :
- 6
- Database :
- Complementary Index
- Journal :
- HemaSphere
- Publication Type :
- Academic Journal
- Accession number :
- 175308845
- Full Text :
- https://doi.org/10.1097/01.HS9.0000850468.09658.81